Drug reference directory
Drug reference

clavulanate

Beta-lactamase inhibitor · Antibiotic (enhancer)

Beta-lactamase inhibitorAntibiotic (enhancer)ATC J01CA04
CDSCO approvedATC J01CA04
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated

Mechanism

Clavulanate is a beta-lactamase inhibitor that protects amoxicillin from degradation by bacterial beta-lactamase enzymes, thereby extending the spectrum of amoxicillin's activity against beta-lactamase-producing bacteria.

Indications

Small intestinal bacterial overgrowth (SIBO, in combination with amoxicillin)

Dosing

Adult
875 mg (amoxicillin) twice daily (in combination with amoxicillin for SIBO, 10-day course).

Pharmacokinetics

Bioavailability
well absorbed by mouth

Side effects

Common
NauseaVomitingHeadache

Drug interactions

Amoxicillin
Moderate
Textbook

Used for prophylaxis of dirty/contaminated surgical wounds.

Source: KDT 7e · p701

Related guidelines

Other Beta-lactamase inhibitor drugs

Ask House about clavulanate

Continue into a citation-backed clinical answer with the drug context already attached.

Textbook-sourced·Sources: Goodman & Gilman 14e·Updated: 2026-05-10